Founder Biotech, Complex trials

Every Decision in a Complex Trial Depends on the One Before It

We connect medical alignment, clinical trial design, biostatistical analysis, and regulatory execution, so your program decisions stay connected instead of siloed.

TALK TO AN EXPERT →
WHERE COMPLEXITY SHOWS UP

Six Reasons Complex Trials Don't Run Themselves

Surrogate-Endpoints-

Surrogate Endpoints

A real clinical outcome can take years to appear. You need a measure that predicts it early enough to act on, and defensible enough to submit
Small-Populations-

Small Populations

Rare disease trials pull from a small patient pool. The design still has to carry enough statistical weight to support a real decision.
organizational-gaps

Adaptive Designs

Trials change once they're underway. Every mid-trial adjustment has to happen without tilting the results toward one outcome.
Global-Sites-

Global Sites

Investigators in different countries work under different norms. Your trial still has to read as one consistent study, not several.
Regulatory-Uncertainty-

Regulatory Uncertainty

Agency expectations shift while a program is already in motion. Falling behind that shift costs time you don't have.
Data-Complexity-

Data Complexity

Genomic data, biomarkers, and clinical outcomes each tell a partial story. None of them mean much until they're read as one.
ONE TEAM FROM DAY ONE

We Bring Every Discipline Together Before the Work Starts

Regulatory specialists, clinical trial designers, medical writers, biostatisticians, and clinical operations leaders are in the room from the start, not brought in after the plan is already set.
Visual-Shell
HOW WE REDUCE RISK

Protocol Decisions Carry Real Risk.
Here's How We Reduce It

Endpoint Alignment-1

Endpoint Alignment

Endpoint choices made too late get expensive to fix. We work through surrogate measures with regulatory agencies early, before a redesign becomes the only option.
Adaptive Modeling-2

Adaptive Modeling

We model how patients are likely to respond, and build adaptive paths that hold up as real trial data comes in.
Data Harmonization-1

Data Harmonization

We coordinate trial execution and statistical programming directly, following CDISC (Clinical Data Interchange Standards Consortium) standards, instead of passing work through separate silos.
WHAT THE NUMBERS SHOW

Results From Complex Clinical Programs

30+

Your regulatory
timeline depends

30+

Your regulatory
timeline depends

30+

Your regulatory
timeline depends

Our Therapeutic Areas of Expertise
CANCER RESEARCH

Oncology & Hematology

Multi-arm designs and tumor metrics change how a trial has to be read. We work through both, along with the endpoints that qualify for fast-track review.
ORPHAN INDICATIONS

Rare Disease

A small patient pool means standard statistical approaches often don't apply. We build the design around the population that actually exists.
NEUROLOGY

Central Nervous System
(CNS) & Neurology

Diagnostic metrics in CNS trials are easy to get wrong, dropout runs higher than in other trial types, and cognitive assessments have to stay consistent across every site.
IMMUNE MECHANISMS

Immunology

Cellular pathways and multiple endpoints generate a lot of overlapping data. We keep it organized so your team can actually use it.
ADVANCED THERAPEUTICS

Cell & Gene Therapy

Follow-up on these programs runs for years, and the regulatory filings get complicated fast. We stay on top of both for the length of the program.
PROPHYLACTICS

Vaccines

Vaccine trials need to enroll participants quickly without losing track of safety monitoring as enrollment scales.
OUR EXPERTS
Expertise That Changes How We Approach Your Program
team-01

Amil Evara

Partner
team-04

Nat Reynolds

Partner
team-03

Suzan Lois

Graphic Designer
team-09

James Oliver

Associate Partner
x
team-01

Amil Evara

Partner
61, Alexandria USA
Egestas congue quisque egestas diam in. Venenatis cras sed felis eget velit aliquet sagittis. In egestas erat imperdiet sed. Viverra maecenas accumsan lacus vel facilisis volutpat est velit. Pretium lectus quam id leo in vitae turpis massa sed. Nibh sed pulvinar proin gravida hendrerit lectus. Semper viverra nam libero justo laoreet sit amet cursus.
x
team-04

Nat Reynolds

Partner
61108 Block Locks, North Otto
Volutpat commodo sed egestas egestas fringilla. Nisl rhoncus mattis rhoncus urna neque viverra justo nec. Feugiat in fermentum posuere urna. Morbi blandit cursus risus at ultrices mi. A diam sollicitudin tempor id eu nisl nunc. Vulputate odio ut enim blandit. Id volutpat lacus laoreet non curabitur gravida arcu ac tortor.
x
team-03

Suzan Lois

Graphic Designer
73421 O'Conner Divide, Cortezmouth
Arcu odio ut sem nulla. Aliquet eget sit amet tellus cras adipiscing enim eu turpis. Tellus cras adipiscing enim eu turpis egestas. Quisque sagittis purus sit amet volutpat consequat mauris. Mauris ultrices eros in cursus turpis massa. Pharetra vel turpis nunc eget. Rhoncus est pellentesque elit ullamcorper dignissim cras tincidunt lobortis feugiat.
x
team-09

James Oliver

Associate Partner
Apt. 843 32344 Schumm Union, Domenicland
Diam donec adipiscing tristique risus nec feugiat. Enim eu turpis egestas pretium aenean pharetra. Porttitor leo a diam sollicitudin tempor id eu nisl. Faucibus in ornare quam viverra orci. Semper risus in hendrerit gravida rutrum quisque. Blandit libero volutpat sed cras. Adipiscing diam donec adipiscing tristique risus nec.
PROOF & RESOURCES
Real Programs, Real Outcomes

 

De-Risk Your Trial Without Sacrificing Speed, Quality, or Cost

Don't build your protocol and scientific path in isolation. Reach out today to align your clinical operations, statistics, and regulatory tracks so your trial moves faster, costs less, and holds up under review.

Frequently Asked Questions